FATE — FATE THERAPEUTICS INC

Ownership history in CITADEL ADVISORS LLC  ·  90 quarters on record

AI Ownership Summary

CITADEL ADVISORS LLC reported FATE THERAPEUTICS INC (FATE) in 90 quarterly 13F filings from 2023 Q3 through 2025 Q4. The latest visible filing shows FATE at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this FATE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CITADEL ADVISORS LLC's position in FATE THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

FATE was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q3 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

FATE stock page CITADEL ADVISORS LLC fund profile CITADEL ADVISORS LLC full holdings
How CITADEL ADVISORS LLC held FATE — position size vs. price
% of Fund (quarterly)    FATE price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 29 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 33,200 -716,136 -95.6% 0.00% $33K 2026-02-14 (Est.) $1.25
2025 Q4 ADDED 749,336 +715,736 +2130.2% 0.00% $736K 2026-02-14 (Est.) $1.25
2025 Q3 REDUCED 33,600 -790,945 -95.9% 0.00% $42K 2025-11-14 $0.96
2025 Q3 ADDED 824,545 +807,045 +4611.7% 0.00% $1.0M 2025-11-14 $0.96
2025 Q3 REDUCED 17,500 -43,600 -71.4% 0.00% $22K 2025-11-14 $0.96
2025 Q2 REDUCED 61,100 -4,482,767 -98.7% 0.00% $68K 2025-08-14 $1.07
2025 Q2 ADDED 4,543,867 +4,530,467 +33809.5% 0.00% $5.1M 2025-08-14 $1.07
2025 Q2 ADDED 13,400 +8,000 +148.1% 0.00% $15K 2025-08-14 $1.07
2025 Q1 REDUCED 5,400 -4,283,759 -99.9% 0.00% $4K 2025-05-15 $1.01
2025 Q1 ADDED 4,289,159 +4,262,459 +15964.3% 0.00% $3.4M 2025-05-15 $1.01
2025 Q1 REDUCED 26,700 -4,355,557 -99.4% 0.00% $21K 2025-05-15 $1.01
2024 Q4 ADDED 4,382,257 +4,366,357 +27461.4% 0.00% $7.2M 2025-02-14 $1.42
2024 Q4 ADDED 15,900 +100 +0.6% 0.00% $26K 2025-02-14 $1.42
2024 Q4 REDUCED 15,800 -4,266,277 -99.6% 0.00% $26K 2025-02-14 $1.42
2024 Q3 ADDED 4,282,077 +4,273,077 +47478.6% 0.00% $15.0M 2024-11-14 $2.08
2024 Q3 ADDED 9,000 +5,300 +143.2% 0.00% $32K 2024-11-14 $2.08
2024 Q3 REDUCED 3,700 -4,484,326 -99.9% 0.00% $13K 2024-11-14 $2.08
2024 Q2 ADDED 4,488,026 +4,474,026 +31957.3% 0.00% $14.7M 2024-08-14 $3.27
2024 Q2 ADDED 14,000 +10,900 +351.6% 0.00% $46K 2024-08-14 $3.27
2024 Q2 REDUCED 3,100 -3,128,426 -99.9% 0.00% $10K 2024-08-14 $3.27
2024 Q1 ADDED 3,131,526 +3,121,926 +32520.1% 0.00% $23.0M 2024-05-15 $4.24
2024 Q1 REDUCED 9,600 -3,900 -28.9% 0.00% $70K 2024-05-15 $4.24
2024 Q1 ADDED 13,500 +2,700 +25.0% 0.00% $99K 2024-05-15 $4.24
2023 Q4 REDUCED 10,800 -2,655,408 -99.6% 0.00% $40K 2024-02-14 $6.49
2023 Q4 ADDED 2,666,208 +2,664,708 +177647.2% 0.00% $10.0M 2024-02-14 $6.49
2023 Q4 ADDED 1,500 +600 +66.7% 0.00% $6K 2024-02-14 $6.49
2023 Q3 REDUCED 900 -7,900 -89.8% 0.00% $2K 2023-11-14 $2.31
2023 Q3 REDUCED 8,800 -2,010,832 -99.6% 0.00% $19K 2023-11-14 $2.31
2023 Q3 REDUCED 2,019,632 -262,899 -11.5% 0.00% $4.3M 2023-11-14 $2.31
61 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding FATE

As of 2025 Q4 — sorted by position size

Redmile Group, LLC 3Y 7Y 0.93% JOHNSON & JOHNSON 3Y 0.6% Bruce & Co., Inc. 3Y 7Y 0.22% Knott David M Jr 3Y 0.17% Monaco Asset Management SAM 3Y 0.14% DAFNA Capital Management LLC 3Y 7Y 0.13% Privium Fund Management B.V. 3Y 0.07% Vestal Point Capital, LP 0.06% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.06% Parametrica Management Ltd 3Y 7Y 0.03%

FAQ About CITADEL ADVISORS LLC and FATE

These are the practical questions this page is built to answer before you even open the full history table.

How long has CITADEL ADVISORS LLC reported owning FATE?

CITADEL ADVISORS LLC reported FATE across 29 quarterly 13F filings, from 2023 Q3 through 2025 Q4.

What was the largest reported FATE position in CITADEL ADVISORS LLC's portfolio?

The largest reported portfolio weight for FATE was 0.00% in 2024 Q1.

What is the latest reported FATE position on this page?

The most recent filing on this page is 2025 Q4, when CITADEL ADVISORS LLC reported 33,200 shares, equal to 0.00% of portfolio, with an estimated market value of $33K.

What does the chart on this FATE ownership page compare?

The chart compares CITADEL ADVISORS LLC's quarterly FATE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to CITADEL ADVISORS LLC Holdings